Table 1.
Distribution (%) of selected cytological diagnoses in different labs in Norway in 2015
| Lab | Normal | ASC-US | LSIL | ASC-H | HSIL |
|---|---|---|---|---|---|
| OUS | 86.9 | 5.0 | 0.9 | 1.0 | 1.1 |
| Lab for pat/Furst | 92.62 | 3.03 | 0.7 | 0.5 | 0.63 |
| HUS1 | 83.6 | 5.0 | 2.4 | 0.8 | 1.42 |
| St.Olav1 | 84.0 | 8.02 | 1.1 | 1.82 | 1.1 |
| Molde | 86.6 | 2.9 | 1.0 | 0.4 | 1.1 |
| Gyn lab/unilabs | 89.9 | 4.9 | 0.8 | 0.7 | 0.63 |
| Østfold | 87.0 | 4.6 | 0.9 | 0.9 | 0.8 |
| UNN | 79.23 | 4.8 | 4.62 | 1.42 | 1.1 |
| Telemark | 88.7 | 3.2 | 2.3 | 0.3 | 1.0 |
| Innlandet,Lillehammer | 93.02 | 3.4 | 0.9 | 0.6 | 0.6 |
| Vestre Viken | 91.1 | 3.6 | 1.8 | 0.6 | 0.9 |
| Ålesund | 91.42 | 5.1 | 1.4 | 0.5 | 0.63 |
| Nordland | 86.4 | 3.6 | 1.9 | 1.1 | 0.8 |
| SUS1 | 84.6 | 4.9 | 2.5 | 0.6 | 1.32 |
| Sørlandet | 89.1 | 3.0 | 1.1 | 0.7 | 0.8 |
| AHUS | 93.42 | 2.5 | 1.5 | 0.8 | 1.0 |
| Vestfold | 83.0 | 8.52 | 2.1 | 2.02 | 0.9 |
| Total | 88.1 | 4.3 | 1.6 | 0.9 | 0.9 |
Adapted from the Norwegian Cancer Screening Programme – annual report 2015 [5]
1Laboratories included in HPV primary screening pilot where women 34 years and older are randomized to Pap smear every three years or HPV test every five years
2Significantly higher than the average for Norway (p<0.05)
3Significantly lower than the average for Norway (p<0.05)